English version

Publications  - 2005

2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 - 1998 - 1997
  1. Adel-Patient K, Ah-Leung S, Creminon C, Nouaille S, Chatel JM, Langella P, Wal JM. (2005). Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization. Clin Exp Allergy. 35,539-546.

  2. Adel-Patient K, Bernard H, Ah-Leung S, Creminon C, Wal JM. (2005). Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin. Allergy. 60,658-664.

  3. Aninat C, Andre F, Delaforge M. (2005). Oxidative metabolism by P450 and function coupling to efflux systems: modulation of mycotoxin toxicity. Food Addit Contam. 22,361-368.

  4. Aractingi S, Kanitakis J, Euvrard S, Le Danff C, Peguillet I, Khosrotehrani K, Lantz O, Carosella ED. (2005). Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res. 65,1755-1760.

  5. Bantubungi K, Jacquard C, Greco A, Pintor A, Chtarto A, Tai K, Galas MC, Tenenbaum L, Deglon N, Popoli P, Minghetti L, Brouillet E, Brotchi J, Levivier M, Schiffmann SN, Blum D. (2005). Minocycline in phenotypic models of Huntington's disease. Neurobiol Dis. 18,206-217.

  6. Barret A, Forestier L, Deslys JP, Julien R, Gallet PF. (2005). Glycosylation-related gene expression in prion diseases: PrPSc accumulation in scrapie infected GT1 cells depends on beta-1,4-linked GalNAc-4-SO4 hyposulfation. Biol Chem. 280, 10516-10523.

  7. Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Beliveau R. (2005). Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin. Cancer Chemother Pharmacol. 56,173-181.

  8. Becard N, de Revel T, Sorg T, Dormont D, Le Grand R. (2005). Expression of human IL-1alpha after intramarrow gene transfer into healthy non-human primate by adenoviral vector. J Med Primatol. 34,1-12.

  9. Belliard G, Hurtrel B, Moreau E, P Lafont BA, Monceaux V, Roques B, Desgranges C, Aubertin AM, Le Grand R, Muller S. (2005). Tat-neutralizing versus Tat-protecting antibodies in rhesus macaques vaccinated with Tat peptides. Vaccine. 23,1399-1407.

  10. Bizat N, Galas MC, Jacquard C, Boyer F, Hermel JM, Schiffmann SN, Hantraye P, Blum D, Brouillet E. (2005). Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. Neuropharmacology. 49,695-702.

  11. Boddaert N, Barthelemy C, Poline JB, Samson Y, Brunelle F, Zilbovicius M. (2005). Autism: functional brain mapping of exceptional calendar capacity. Br J Psychiatry. 187,8386.

  12. Boddaert N, Ribeiro M, Touati G, Mention K, Valayanopoulos V, Nihoul-Fekete C, Brunelle F, de Lonlay P. (2005). Radiological innovations in the diagnosis of the metabolic diseases: spectroscopy and cerebral MRI in creatine deficiencies, polyols anomalies, and metabolites on the pentose pathway-positron emission tomography (PET) after injection of [18F]Fluoro-L-Dopa in congenital hyperinsulinism. Med Sci (Paris). 21,981-986.

  13. Boisgard R, Kuhnast B, Vonhoff S, Younes C, Hinnen F, Verbavatz JM, Rousseau B, Furste JP, Wlotzka B, Dolle F, Klussmann S, Tavitian B. (2005). In vivo biodistribution and pharmacokinetics of (18)F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 32,470-477.

  14. Bonvento G, Herard AS, Voutsinos-Porche B. (2005). The astrocyte-neuron lactate shuttle: a debated but still valuable hypothesis for brain imaging. J Cereb Blood Flow Metab. 25,1394-1399.

  15. Boschetto P, Miotto D, Bononi I, Faggian D, Plebani M, Papi A, Creminon C, De Rosa E, Fabbri LM, Mapp CE. (2005). Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 18,199-205.

  16. Bouchonnet F, Dam E, Mammano F, de Soultrait V, Hennere G, Benech H, Clavel F, Hance AJ. (2005). Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues. J Virol. 79,812-822.

  17. Bouilleret V, Semah F, Biraben A, Taussig D, Chassoux F, Syrota A, Ribeiro MJ. (2005). Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis. J Nucl Med. 46,540-547.

  18. Boumezbeur F, Besret L, Valette J, Gregoire MC, Delzescaux T, Maroy R, Vaufrey F, Gervais P, Hantraye P, Bloch G, Lebon V. (2005). Glycolysis versus TCA cycle in the primate brain as measured by combining 18F-FDG PET and 13C-NMR. J Cereb Blood Flow Metab. 25,1418-1423.

  19. Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Giorgio MD, Carosella ED. (2005). Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging. 32,229-246.

  20. Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Giorgio MD, Carosella ED. (2005). Genetic and epigenetic features in radiation sensitivity Part II: implications for clinical practice and radiation protection. Eur J Nucl Med Mol Imaging. 32,351-368.

  21. Brasse D, Kinahan PE, Lartizien C, Comtat C, Casey M, Michel C. (2005). Correction Methods for Random Coincidences in Fully 3D Whole-Body PET: Impact on Data and Image Quality. J Nucl Med. 46,859-867.

  22. Brouillet E, Jacquard C, Bizat N, Blum D. (2005). 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem. 95,1521-1540.

  23. Buffon F, Molko N, Herve D, Porcher R, Denghien I, Pappata S, Le Bihan D, Bousser MG, Chabriat H. (2005). Longitudinal diffusion changes in cerebral hemispheres after MCA infarcts. J Cereb Blood Flow Metab. 25,641-650.

  24. Carlier PG, Bertoldi D. (2005). In vivo functional NMR imaging of resistance artery control. Am J Physiol Heart Circ Physiol. 288,H1028-1036.

  25. Cerchia L, Duconge F, Pestourie C, Boulay J, Aissouni Y, Gombert K, Tavitian B, de Franciscis V, Libri D. (2005). Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3,e123.

  26. Chabert S, Molko N, Cointepas Y, Le Roux P, Le Bihan D. (2005). Diffusion tensor imaging of the human optic nerve using a non-CPMG fast spin echo sequence. J Magn Reson Imaging. 22,307-310.

  27. Clement G, Boquet D, Mondoulet L, Lamourette P, Bernard H, Wal JM. (2005). Expression in Escherichia coli and disulfide bridge mapping of PSC33, an allergenic 2S albumin from peanut. Protein Expr Purif. 44,110-120.

  28. Cohen L, Jobert A, Le Bihan D, Dehaene S. (2004) Distinct unimodal and multimodal regions for word processing in the left temporal cortex. Neuroimage. 23,1256-1270.

  29. Cohen-Solal A, Rouzet F, Berdeaux A, Le Guludec D, Abergel E, Syrota A, Merlet P. (2005). Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. J Nucl Med. 46,1796-1803.

  30. Colin E, Regulier E, Perrin V, Durr A, Brice A, Aebischer P, Deglon N, Humbert S, Saudou F. (2005). Akt is altered in an animal model of Huntington's disease and in patients. Eur J Neurosci. 21,1478-1488.

  31. Compain S, Schlemmer D, Levi M, Pruvost A, Goujard C, Grassi J, Benech H. (2005). Development and validation of a liquid chromatographic/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matrices. J Mass Spectrom. 40,9-18.

  32. De Bruin B, Kuhnast B, Hinnen F, Yaouancq L, Amessou M, Johannes L, Samson A, Boisgard R, Tavitian B, Dolle F. (2005). 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconjug Chem. 16,406-420.

  33. de Lonlay P, Giurgea I, Sempoux C, Touati G, Jaubert F, Rahier J, Ribeiro MJ, Brunelle F, Nihoul-Fekete C, Robert JJ, Saudubray JM, Stanley C, Bellanne-Chantelot C. (2005). Dominantly inherited hyperinsulinaemic hypoglycaemia. J Inherit Metab Dis. 28, 267-276.

  34. Debruyne D, Quentin T, Poisnel G, Lelong-Boulouard V, Barre L, Coquerel A. (2005). Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain. Brain Res. 1052,222-231.

  35. Deglon N, Hantraye P. (2005). Viral vectors as tools to model and treat neurodegenerative disorders. J Gene Med. 7,530-539.

  36. Dehaene S, Changeux JP. (2005). Ongoing Spontaneous Activity Controls Access to Consciousness: A Neuronal Model for Inattentional Blindness. PLoS Biol. 3,:e141.

  37. Dehaene S, Cohen L, Sigman M, Vinckier F. (2005). The neural code for written words: a proposal. Trends Cogn Sci. 9,335-341.

  38. Dehaene-Lambertz G, Pallier C, Serniclaes W, Sprenger-Charolles L, Jobert A, Dehaene S. (2005). Neural correlates of switching from auditory to speech perception. Neuroimage. 24,21-33.

  39. Delaforge M, Pruvost A, Perrin L, Andre F. (2005). Cytochrome P450-mediated oxidation of glucuronide derivatives: example of estradiol-17beta-glucuronide oxidation to 2-hydroxy-estradiol-17beta-glucuronide by CYP 2C8. Drug Metab Dispos. 33,466-473.

  40. Delmaire C, Krainik A, Tezenas du Montcel S, Gerardin E, Meunier S, Mangin JF, Sangla S, Garnero L, Vidailhet M, Lehericy S. (2005). Disorganized somatotopy in the putamen of patients with focal hand dystonia. Neurology. 64,1391-1396.

  41. Delys JP, Grassi J. (2005). Screening tests for animal TSE: present and future. Pathol Biol (Paris). 53,221-228.

  42. Dodel S, Golestani N, Pallier C, Elkouby V, Le Bihan D, Poline JB. (2005). Condition-dependent functional connectivity: syntax networks in bilinguals. Philos Trans R Soc Lond B Biol Sci. 360,921-935.

  43. Dolffuls S, Razafimandimby A, Delamillieure P, Brazo P, Joliot M, Mazoyer B, Tzourio-Mazoyer N. (2005). Atypical hemispheric specialization for language in right-handed schizophrenia patients. Biol Psychiatry. 57,1020-1028.

  44. Dollé F, Martarello L, Bramoullé Y, Bottlaender M, Gee AD. (205). Radiosynthesis of carbon-11-labeleld GI181771, a new selective CCK-A agonist. J Label Compd Radiopharm. 48,501-513.

  45. Dollé F. (2005). Fluorine-18-labelled fluopyridines : advances in radiopharmaceutical design. Cur Pharm Design. 11,3221-3235.

  46. Dubois J, Lethimonnier F, Vaufrey F, Robert P, Bihan DL. (2005). Frequency-shift based detection of BMS contrast agents using SSFP: potential for MRA. Magn Reson Imaging. 23,453-462.

  47. Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C; PROGRESS MRI Substudy Investigators. (2005). Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation. 112,1644-1650.

  48. Duvelleroy D, Perrio C, Parisel O, Lasne MC. (2005). Rapid synthesis of quinoline-4-carboxylic acid derivatives from arylimines and 2-substituted acrylates or acrylamides under indium(III) chloride and microwave activations. Scope and limitations of the reaction. Org Biomol Chem. 3,3794-3804.

  49. Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, Lilin T, Messiaen S, Andreoletti O, Baron T, Bencsik A, Biacabe AG, Beringue V, Laude H, Le Dur A, Vilotte JL, Comoy E, Deslys JP, Grassi J, Simon S, Lantier F, Sarradin P. (2005). BSE agent signatures in a goat. Vet Rec. 156,523-524.

  50. Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, Lilin T, Messiaen S, Andreoletti O, Baron T, Bencsik A, Biacabe AG, Beringue V, Laude H, Le Dur A, Vilotte JL, Comoy E, Deslys JP, Grassi J, Simon S, Lantier F, Sarradin P. (2005). BSE agent signatures in a goat. Vet Rec. 156,523-524.

  51. Erfle V, Goebel FD, Guzman CA, Le Grand R. (2005). Vaccines based on Nef and on Nef/DeltaV2. Env.Microbes Infect. 7,1400-1404.

  52. Feraudet C, Morel N, Simon S, Volland H, Frobert YF, Creminon C, Vilette D, Lehmann S, Grassi J. (2005). Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem. 280,11247-11258.

  53. Fritsche R, Adel-Patient K, Bernard H, Martin-Paschoud C, Schwarz C, Ah-Leung S, Wal JM. (2005). IgE-mediated rat mast cell triggering with tryptic and synthetic peptides of bovine beta-lactoglobulin. Int Arch Allergy Immunol.138,291-297.

  54. Gallezot JD, Bottlaender M, Gregoire MC, Roumenov D, Deverre JR, Coulon C, Ottaviani M, Dolle F, Syrota A, Valette H. (2005). In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. J Nucl Med. 46,240-247.

  55. Gendry Meresse I, Zilbovicius M, Boddaert N, Robel L, Philippe A, Sfaello I, Laurier L, Brunelle F, Samson Y, Mouren MC, Chabane N. (2005). Autism severity and temporal lobe functional abnormalities. Ann Neurol. 58,466-469.

  56. Giurgea I, Ribeiro MJ, Boddaert N, Touati G, Robert JJ, Saudubray JM, Jaubert F, Bellanne-Chantelot C, Brunelle F, Nihoul-Fekete C, de Lonlay P. (2005). Congenital hyperinsulinism in newborn and infant. Arch Pediatr. 12,1628-1635.

  57. Gonzáles-Hernandez A, LeMaoult J, Lopez A, Alegre E, Caumartin J, Le Rond S, Daouya M, Moreau Ph, Carosella ED. (2005). Linking two Immuno-Suppressive Molecules: Indoleamine 2,3 Dioxygenase Can Modify HLA-G Cell-Sufarce Expression. Biology Reproduction.73,571-578.

  58. Halley A, Hugentobler A, Icard P, Porret E, Sobrio F, Lerochais JP, Bouvard G, Zalcman G, Agostini D. (2005). Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 32,1026-1032.

  59. Herard AS, Dubois A, Escartin C, Tanaka K, Delzescaux T, Hantraye P, Bonvento G. (2005). Decreased metabolic response to visual stimulation in the superior colliculus of mice lacking the glial glutamate transporter GLT-1. Eur J Neurosci. 22,1807-1811.

  60. Herve D, Mangin JF, Molko N, Bousser MG, Chabriat H  (2005). Shape and volume of lacunar infarcts: a 3D MRI study in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 36,2384-2388.

  61. Herve D, Molko N, Pappata S, Buffon F, LeBihan D, Bousser MG, Chabriat H. (2005). Longitudinal thalamic diffusion changes after middle cerebral artery infarcts. J Neuro Neurosurg Psychiatry. 76,200-205.

  62. Herve PY, Mazoyer B, Crivello F, Perchey G, Tzourio-Mazoyer N. (2005). Finger tapping, handedness and grey matter amount in the Rolando's genu area. Neuroimage. 25,1133-1145.

  63. Herzog C, Riviere J, Lescoutra-Etchegaray N, Charbonnier A, Leblanc V, Sales N, Deslys JP, Lasmezas CI. (2005). PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease. J Virol. 79,14339-14345.

  64. Hubbard EM, Piazza M, Pinel P, Dehaene S. (2005). Interactions between number and space in parietal cortex. Nat Rev Neurosci. 6,435-448.

  65. Jacquemot C, Cuche C, Dormont D, Lazarini F. (2005). High incidence of scrapie induced by repeated injections of subinfectious prion doses. J Virol. 79,8904-8908.

  66. James ML, Fulton RR, Henderson DJ, Eberl S, Meikle SR, Thomson S, Allan RD, Dolle F, Fulham MJ, Kassiou M. (2005). Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand. Bioorg Med Chem. 13,6188-6194.

  67. Jilek A, Mollay C, Tippelt C, Grassi J, Mignogna G, Mullegger J, Sander V, Fehrer C, Barra D, Kreil G. (2005). Biosynthesis of a D-amino acid in peptide linkage by an enzyme from frog skin secretions. Proc Natl Acad Sci U S A. 102,4235-4239.

  68. Kirik D, Breysse N, Bjorklund T, Besret L, Hantraye P. (2005). Imaging in cell-based therapy for neurodegenerative diseases. Eur J Nucl Med Mol Imaging. 32 Suppl 2,S417-S434.

  69. Kochunov P, Mangin JF, Coyle T, Lancaster J, Thompson P, Riviere D, Cointepas Y, Regis J, Schlosser A, Royall DR, Zilles K, Mazziotta J, Toga A, Fox PT. (2005). Age-related morphology trends of cortical sulci. Hum Brain Mapp. 26,210-220.

  70. Kolesnikov-Gauthier H, Levy E, Merlet P, Kirova J, Syrota A, Carpentier P, Meignan M, Piedbois P. (2005). FDG PET in patients with cancer of an unknown primary. Nucl Med Commun. 26,1059-1066.

  71. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, Apetrei C, Poaty-Mavoungou V, Rouquet P, Estaquier J, Mortara L, Desoutter JF, Butor C, Le Grand R, Roques P, Simon F, Barre-Sinoussi F, Diop OM, Muller-Trutwin MC. (2005). Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. Clin Invest. 115,1082-1091.

  72. Lafaye A, Junot C, Pereira Y, Lagniel G, Tabet JC, Ezan E, Labarre J. (2005). Combined proteome and metabolite-profiling analyses reveal surprising insights into yeast sulfur metabolism. J Biol Chem. 280,24723-24730.

  73. Lafaye A, Labarre J, Tabet JC, Ezan E, Junot C. (2005). Liquid chromatography-mass spectrometry and 15N metabolic labeling for quantitative metabolic profiling. Anal Chem. 77,2026-2033.

  74. Laffont-Proust I, Faucheux BA, Hassig R, Sazdovitch V, Simon S, Grassi J, Hauw JJ, Moya KL, Haik S. (2005). The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett. 579, 6333-6337.

  75. Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED. (2005). Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections. J. Virol.79,15226-15237.

  76. Lasmezas CI, Comoy E, Hawkins S, Herzog C, Mouthon F, Konold T, Auvre F, Correia E, Lescoutra-Etchegaray N, Sales N, Wells G, Brown P, Deslys JP. (2005). Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet. 365,781-783.

  77. Le Discorde M, Le Danff C, Moreau P, Rouas-Freiss N, Carosella ED. (2005). HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms. Biol Reprod. 73,571-578.

  78. Le Rond S, Gonzalez A, Gonzalez AS, Carosella ED, Rouas-Freiss N. (2005). Indoleamine 2,3 Dioxygenase and Human Leucocyte Antigen-G Inhibit the T-Cell Alloproliferative Response Throught Two Independent Pathways.Immunology.116, 297-307.

  79. Lemaitre H, Crivello F, Dufouil C, Grassiot B, Tzourio C, Alperovitch A, Mazoyer B. (2005). No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage. 24,1205-1213.

  80. Lemaitre H, Crivello F, Grassiot B, Alperovitch A, Tzourio C, Mazoyer B. (2005). Age- and sex-related effects on the neuroanatomy of healthy elderly. Neuroimage. 26,900-911.

  81. LeMaoult J, Rouas-Freiss N, Carrosella ED. (2005). Immuno-Tolerogenic Functions of HLA-G: Relevance in Transplantation and Oncology. Autoimmunity Reviews. 4,503-509.

  82. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. (2005). HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 19,662-664.

  83. Leroy-Willig A, Bureau MF, Scherman D, Carlier PG. (2005). In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle. Gene Ther. 12,1434-1443.

  84. Lourdel S, Loffing J, Favre G, Paulais M, Nissant A, Fakitsas P, Creminon C, Feraille E, Verrey F, Teulon J, Doucet A, Deschenes G. (2005). Hyperaldosteronemia and Activation of the Epithelial Sodium Channel Are Not Required for Sodium Retention in Puromycin-Induced Nephrosis. J Am Soc Nephrol. 16,3642-3650.

  85. Maignien T, Shakweh M, Calvo P, Marce D, Sales N, Fattal E, Deslys JP, Couvreur P, Lasmezas CI. (2005). Role of gut macrophages in mice orally contaminated with scrapie or BSE. Int J Pharm. 298,293-304.

  86. Martin C, Plat M, Nerriere-Daguin V, Coulon F, Uzbekova S, Venturi E, Conde F, Hermel JM, Hantraye P, Tesson L, Anegon I, Melchior B, Peschanski M, Le Mauff B, Boeffard F, Sergent-Tanguy S, Neveu I, Naveilhan P, Soulillou JP, Terqui M, Brachet P, Vanhove B. (2005). Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. Transgenic Res. 14,373-384.

  87. Mauger G, Saba W, Hantraye P, Dolle F, Coulon C, Bramoulle Y, Chalon S, Gregoire MC. (2005). Multiinjection approach for D2 receptor binding quantification in living rats using [11C]raclopride and the beta-microprobe: crossvalidation with in vitro binding data. J Cereb Blood Flow Metab. 25,1517-1527.

  88. Mayer-Sonnenfeld T, Zeigler M, Halimi M, Dayan Y, Herzog C, Lasmezas CI, Gabizon R. (2005). The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiol Dis. 20,738-743.

  89. Mazard A, Laou L, Joliot M, Mellet E. (2005). Neural impact of the semantic content of visual mental images and visual percepts. Brain Res Cogn Brain Res. 24,423-435.

  90. Menu E, Muller-Trutwin MC, Pancino G, Saez-Cirion A, Bain C, Inchauspe G, Gras GS, Mabondzo AM, Samri A, Boutboul F, Grand RL. (2005). First Dominique Dormont international conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections”. Retrovirology. 2,24.

  91. Meunier S, Hanedanian M, Desage-El Murr M, Nowaczyk S, Le Gall T, Pin S, Renault JP, Boquet D, Creminon C, Mioskowski C, Taran F. (2005). High-throughput evaluation of antioxidant and pro-oxidant activities of polyphenols with thymidine protection assays. Chembiochem. 6,1234-1241.

  92. Mitkovski S, Villemagne VL, Novakovic KE, O'Keefe G, Tochon-Danguy H, Mulligan RS, Dickinson KL, Saunder T, Gregoire MC, Bottlaender M, Dolle F, Rowe CC. (2005). Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. Nucl Med Biol. 32,585-591.

  93. Mondoulet L, Paty E, Drumare MF, Ah-Leung S, Scheinmann P, Willemot RM, Wal JM, Bernard H. (2005). Influence of thermal processing on the allergenicity of peanut proteins. J Agric Food Chem. 53,4547-4553.

  94. Moog-Lutz C, Degoutin J, Gouzi JY, Frobert Y, Brunet-de Carvalho N, Bureau J, Creminon C, Vigny M. (2005). Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin. J Biol Chem. 280,26039-26048.

  95. Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, Grassi J, Rousset M, Dormont D, Chambaz J. (2005). Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am J Pathol. 167,1033-1042.

  96. Mouillot G, Marcou C, Rousseau P, Rouas-Freiss N, Carosella ED, Moreau P. (2005). HLA-G gene activation in tumor cells involves cis-acting epigenetic changes. Int J Cancer. 113,928-36.

  97. Moya KL, Hassig R, Breen KC, Volland H, Di Giamberardino L. (2005). Axonal transport of the cellular prion protein is increased during axon regeneration. J Neurochem. 92,1044-1053.

  98. Naccache L, Gaillard R, Adam C, Hasboun D, Clemenceau S, Baulac M, Dehaene S, Cohen L. (2005). A direct intracranial record of emotions evoked by subliminal words. Proc Natl Acad Sci U S A. 102,7713-7717.

  99. Nakamura K, Dehaene S, Jobert A, Le Bihan D, Kouider S. (2005). Subliminal convergence of Kanji and Kana words: further evidence for functional parcellation of the posterior temporal cortex in visual word perception. J Cogn Neurosci. 17,954-968.

  100. Nguyen S, Dhedin N, Vernant JP, Kuentz M, Jijakli AA, Rouas-Freiss N, Carosella ED, Boudifa A, Debre P, Vieillard V. (2005). NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood. 105,4135-4142.

  101. Nichols T, Brett M, Andersson J, Wager T, Poline JB. (2005). Valid conjunction inference with the minimum statistic. Neuroimage. 25,653-660.

  102. Nouaille S, Bermudez-Humaran LG, Adel-Patient K, Commissaire J, Gruss A, Wal JM, Azevedo V, Langella P, Chatel JM. (2005). Improvement of bovine ss-lactoglobulin production and secretion by Lactococcus lactis. Braz J Med Biol Res. 38,353-359.

  103. Pandrea I, Kornfeld C, Ploquin MJ, Apetrei C, Faye A, Rouquet P, Roques P, Simon F, Barre-Sinoussi F, Muller-Trutwin MC, Diop OM. (2005). Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol. 79,6249-6259.

  104. Pelerin H, Compain S, Duval X, Gimenez F, Benech H, Mabondzo A. (2005). Development of an assay method for the detection and quantification of protease and non-nucleoside reverse transcriptase inhibitors in plasma and in peripherical blood mononuclear cells by liquid chromatography coupled with ultraviolet or tandem mass spectrometry detection. J Chromatogr B Analyt Technol Biomed Life Sci. 819,47-57.

  105. Perrin M, Poupon C, Rieul B, Leroux P, Constantinesco A, Mangin JF, Lebihan D. (2005). Validation of q-ball imaging with a diffusion fibre-crossing phantom on a clinical scanner. Philos Trans R Soc Lond B Biol Sci. 360,881-891.

  106. Pestourie C, Tavitian B, Duconge F. (2005). Aptamers against extracellular targets for in vivo applications. Biochimie. 87,921-930.

  107. Phan G, Herbet A, Cholet S, Benech H, Deverre JR, Fattal E. (2005). Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation. J Control Release. 110,177-188.

  108. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G. (2005). Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol. 142,481-489.

  109. Pouthas V, George N, Poline JB, Pfeuty M, Vandemoorteele PF, Hugueville L, Ferrandez AM, Lehericy S, Lebihan D, Renault B. (2005). Neural network involved in time perception: An fMRI study comparing long and short interval estimation. Hum Brain Mapp. 25,433-441.

  110. Pruvost A, Negredo E, Benech H, Theodoro F, Puig J, Grau E, Garcia E, Molto J, Grassi J, Clotet B. (2005). Measurement of intracellular Didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 49,1907-1914.

  111. Puaux AL, Delache B, Marconi S, Huerre M, Le Grand R, Riviere Y, Michel ML. (2005). Loss of reactivity of vaccine-induced CD4 T cells in immunized monkeys after SIV/HIV challenge. AIDS. 19,757-765.

  112. Quentin T, Debruyne D, Lelong-Boulouard V, Poisnel G, Barre L, Coquerel A. (2005). Clorazepate affects cell surface regulation of delta and kappa opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain. Brain Res. 1063,84-95.

  113. Rebmann V., LeMaoult J., Rouas-Freiss N., Carosella E.D., Grosse-Wilde H. (2005). Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Human-Immunology. 66, 853-63.

  114. Regis J, Mangin JF, Ochiai T, Frouin V, Riviere D, Cachia A, Tamura M, Samson Y. (2005). Sulcal root" generic model: a hypothesis to overcome the variability of the human cortex folding patterns. Neurol Med Chir (Tokyo). 45,1-17.

  115. Remy P, Doder M, Lees A, Turjanski N, Brooks D. (2005). Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain. 28,1314-1322.

  116. Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, Dolle F, Nihoul-Fekete C, Syrota A, Brunelle F. (2005). Characterization of Hyperinsulinism in Infancy Assessed with PET and 18F-Fluoro-L-DOPA. J Nucl Med. 46,560-566.

  117. Ribeiro MJ, Ricard M, Bourgeois S, Lievre MA, Bottlaender M, Gervais P, Dolle F, Syrota A. (2005). Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers. Eur J Nucl Med Mol Imaging. 32,952-958.

  118. Robert P, Violas X, Santus R, Le Bihan D, Corot C. (2005). Optimization of a blood pool contrast agent injection protocol for MR angiography. J Magn Reson Imaging. 21,611-619.

  119. Rogez-Kreuz C, Maneglier B, Dereuddre-Bosquet N, Dormont D, Clayette P. (2005). Lack of IFN-gamma production in response to antigenic stimulation in human IFN-tau-treated lymphocytes. J Interferon Cytokine Res. 25,444-452.

  120. Rogez-Kreuz C, Maneglier B, Martin M, Dereuddre-Bosquet N, Martal J, Dormont D, Clayette P. (2005). Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-tau in human macrophages. Int Immunol. 17,1047-1057.

  121. Rouas-Freiss N, Moreau Ph, Ferrone S, Carosella ED. (2005) HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism? Cancer Res. 65,10139-10144.

  122. Rouas-Freiss N., Bruel S., Menier C., Marcou C., Moreau Ph., Carosella E.D. (2005). Switch of HLA-G Alternative Splicing in a Melanoma Cell Line Causes Loss of HLA-G1 Expression and Sensitivity to NK Lysis. Int. J. Cancer.117,114-122.

  123. Rusu V, Chassoux F, Landre E, Bouilleret V, Nataf F, Devaux BC, Turak B, Semah F. (2005). Dystonic posturing in seizures of mesial temporal origin: electroclinical and metabolic patterns. Neurology. 65,1612-1619.

  124. Sabuncu E, Paquet S, Chapuis J, Moudjou M, Lai TL, Grassi J, Baron U, Laude H, Vilette D. (2005). Prion proteins from susceptible and resistant sheep exhibit some distinct cell biological features. Biochem Biophys Res Commun. 337,791-798.

  125. Semah F, Rivlin P. (2005). Can we predict refractory epilepsy at the time of diagnosis? Epileptic Disord. 7 Suppl 1,10-13.

  126. Sergent C, Baillet S, Dehaene S. (2005). Timing of the brain events underlying access to consciousness during the attentional blink. Nat Neurosci. 8,1391-1400.

  127. Sergent C, Dehaene S. (2005). Neural processes underlying conscious perception: experimental findings and a global neuronal workspace framework. J Physiol Paris. 98,374-384.

  128. Sigman M, Dehaene S. (2005). Parsing a cognitive task: a characterization of the mind's bottleneck. PLoS Biol. 3,e37.

  129. Sobrio F, Debruyne D, Dhilly M, Chazalviel L, Camsonne R, Kakiuchi T, Tsukada H, Barre L. (2005). Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography. Neurochem Int. 46,479-488.

  130. Tavitian B. (2005). Oligonucleotides as radiopharmaceuticals. Ernst Schering Res Found Workshop. 49,1-34

  131. Thiebot H, Vaslin B, Derdouch S, Bertho JM, Mouthon F, Prost S, Gras G, Ducouret P, Dormont D, Le Grand R. (2005). Impact of bone marrow hematopoiesis failure on T-cell generation during pathogenic simian immunodeficiency virus infection in macaques. Blood. 105,2403-2409.

  132. Todorova-Balvay D, Simon S, Creminon C, Grassi J, Srikrishnan T, Vijayalakshmi MA. (2005). Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches. J Chromatogr B Analyt Technol Biomed Life Sci. 818,75-82.

  133. Trevisani M, Patacchini R, Nicoletti P, Gatti R, Gazzieri D, Lissi N, Zagli G, Creminon C, Geppetti P, Harrison S. (2005). Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol. 145,1123-1131.

  134. Valette H, Bottlaender M, Dolle F, Coulon C, Ottaviani M, Syrota A. (2005). Acute effects of physostigmine and galantamine on the binding of [(18)F]fluoro-A-85380: A PET study in monkeys. Synapse. 56,217-221.

  135. Valette H, Bottlaender M, Dolle F, Coulon C, Ottaviani M, Syrota A. (2005). Acute inhibition of cardiac monoamine oxidase A following tobacco smoke inhalation. Validation study of [11C]befloxatone in rats followed by a PET application in baboons. J Pharmacol Exp Ther. 314,431-436.

  136. Valette J, Guillermier M, Besret L, Boumezbeur F, Hantraye P, Lebon V. (2005). Optimized diffusion-weighted spectroscopy for measuring brain glutamate apparent diffusion coefficient on a whole-body MR system. NMR Biomed. 18,527-533.

  137. van Cuyck H, Fan J, Robertson DL, Roques P. (2005). Evidence of recombination between divergent hepatitis E viruses. J Virol. 79,9306-9314.

  138. Verani A, Gras G, Pancino G. (2005). Macrophages and HIV-1: dangerous liaisons. Mol Immunol. 42,195-212.

  139. Viard A, Flament MF, Artiges E, Dehaene S, Naccache L, Cohen D, Mazet P, Mouren MC, Martinot JL. (2005). Cognitive control in childhood-onset obsessive-compulsive disorder: a functional MRI study. Psychol Med. 35,1007-1017.

  140. Vicennati P, Bensel N, Wagner A, Creminon C, Taran F. (2005). Sandwich immunoassay as a high-throughput screening method for cross-coupling reactions. Angew Chem Int Ed Engl. 44,6863-6866.

  141. Vigneau M, Jobard G, Mazoyer B, Tzourio-Mazoyer N. (2005). Word and non-word reading: what role for the Visual Word Form Area? Neuroimage. 27,694-705.

  142. Volland H, Neuburger LM, Schultz E, Grassi J, Perraut F, Creminon C. (2005). Solid-phase immobilized tripod for fluorescent renewable immunoassay. A concept for continuous monitoring of an immunoassay including a regeneration of the solid phase. Anal Chem. 77,1896-1904.

  143. Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, Zurn AD, Aebischer P, Deglon N. (2005). Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol Dis. 20,785-798.

2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 - 1998 - 1997